JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2025, 74(4):252-257 | DOI: 10.36290/csf.2025.041

Selected case reports from the practice of a clinical pharmacist in the field of pneumology

Blanka Pelantová1, Petra Halvová1, Petra Rozsívalová1, 2, Lenka Dejdarová3, Vladimír Koblížek4, Filip Gabalec5, Josef Malý2
1 Oddělení klinické farmacie, Nemocniční lékárna, Fakultní nemocnice Hradec Králové
2 Katedra sociální a klinické farmacie, Farmaceutická fakulta v Hradci Králové, Univerzita Karlova
3 Ordinace praktického lékaře a endokrinologa, Vysoké Mýto
4 Plicní klinika FN a Lékařská fakulta Univerzity Karlovy v Hradci Králové
5 IV. interní hematologická klinika FN a Lékařská fakulta Univerzity Karlovy v Hradci Králové

This article presents three case studies highlighting complex pharmacotherapeutic challenges and the role of a clinical pharmacist in clinical practice. The first case describes the long-term treatment of avian mycobacteriosis (MAC - Mycobacterium avium complex) in a patient with cystic fibrosis. It details the patient's history of multi-drug resistant MAC infection, numerous antituberculosis regimens, and significant drug intolerances, emphasizing the need for careful consideration of drug interactions, particularly with cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The second case focuses on the management of a drug interaction between rifampicin and levothyroxine. It describes a patient with hypothyroidism whose levothyroxine the­rapy was destabilized by the co-administration of rifampicin, a potent enzyme inducer. This case highlights the critical need for proactive management and careful monitoring of thyroid function in patients receiving both levothyroxine and rifampicin. The third case explores a potential intoxication by menthol and eucalyptus in a patient attempting to quit smoking, who consumed excessive amounts of menthol-eucalyptus lozenges. This case illustrates how seemingly harmless over-the-counter products can lead to adverse effects when consumed in large quantities, underscoring the importance of a detailed dietary history. Overall, these case studies underscore the role of a clinical pharmacist in complex pharmacotherapeutic problems, the importance of interdisciplinary collaboration, and individualized patient care in managing challenging clinical scenarios.

Keywords: smoking cessation, intoxication, menthol, antituberculosis drugs, mycobacteriosis, CFTR modulators, rifampicin, drug interaction, cystic fibrosis.

Accepted: November 21, 2025; Published: December 5, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pelantová B, Halvová P, Rozsívalová P, Dejdarová L, Koblížek V, Gabalec F, Malý J. Selected case reports from the practice of a clinical pharmacist in the field of pneumology. Čes. slov. farm. 2025;74(4):252-257. doi: 10.36290/csf.2025.041.
Download citation

References

  1. Prieto MD, Alam ME, Franciosi AN, Quon BS. Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis. ERJ Open Res. 2023 Jan 3;9(1):00336-2022. Go to original source... Go to PubMed...
  2. Fila L, Jakubec P. Léčba plicních netuberkulózních mykobakterióz: Poziční dokument. Online. Plicnilekarstvi.cz. 2023. Available from: https://www.plicnilekarstvi.cz/guidelines/. [cit. 2025-08-12].
  3. 3 Bedaquiline. Online. DrugBank 2013. . Available from: https://go.drugbank.com/drugs/DB08903. [cit. 2025-09-08].
  4. Nettis MA. Minocycline in Major Depressive Disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders. Brain Behav Immun Health. 2021 Aug 24;17:100335 Go to original source... Go to PubMed...
  5. Interakce. Online. UpToDate Lexidrug. 2025. . Available from: https://online.lexi.com/lco/action/interact. [cit. 2025-09-08].
  6. Databáze lékových interakcí. Online. Databáze lékových interakcí. 2025. Available from: https://lekoveinterakce.cz/kontrola-preskripce. [cit. 2025-09-08].
  7. SmPC Sirturo. Online. SÚKL. 2014, 2024-07-12. . Available from: https://prehledy.sukl.cz/prehled_leciv.html#/leciva/0194812. [cit. 2025-09-08]
  8. Bassett B, Subramaniyam S, Fan Y, Varney S, Pan H, Carneiro AMD, Chung CY. Minocycline alleviates depression-like symptoms by rescuing decrease in neurogenesis in dorsal hippocampus via blocking microglia activation/phagocytosis. Brain Behav Immun. 2021 Jan;91:519-530. Go to original source... Go to PubMed...
  9. Isley WL. Effect of rifampin therapy on thyroid function tests in a hypothyroid patient on replacement L-thyroxine. Ann Intern Med. 1987 Oct;107(4):517-8 Go to original source... Go to PubMed...
  10. Naher K, Samsuddoha K, Karam JG. LBODP105 A Case of Significantly Increased Levothyroxine Requirement With Rifampin Therapy. J Endocr Soc. 2022 Nov Go to original source...
  11. Nolan SR, Self TH, Norwood JM. Interaction between rifampin and levothyroxine. South Med J. 1999 May;92(5):529-31. Go to original source... Go to PubMed...
  12. Kim HI, Kim TH, Kim H, et al. Effect of Rifampin on Thyroid Function Test in Patients on Levothyroxine Medication. PLoS One. 2017 Jan 12;12(1):e0169775. Go to original source... Go to PubMed...
  13. Goldberg AS, Tirona RG, Asher LJ. Ciprofloxacin and rifampin have opposite effects on levothyroxine absorption. Thyroid. 2013 Nov;23(11):1374-8. Go to original source... Go to PubMed...
  14. Finke C, Juge C, Goumaz M, Kaiser O, Davies R, Burger AG. Effects of rifampicin on the peripheral turnover kinetics of thyroid hormones in mice and in men. J Endocrinol Invest. 1987 Apr;10(2):157-62. Go to original source... Go to PubMed...
  15. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012 Nov-Dec;18(6):988-1028. Go to original source... Go to PubMed...
  16. Liu H, Li W, Zhang W, et al. Levothyroxine: Conventional and Novel Drug Delivery Formulations. Endocr Rev. 2023 May 8;44(3):393-416. Go to original source... Go to PubMed...
  17. Kumar KJ, Sonnathi S, Anitha C, Santhoshkumar M. Eucalyptus Oil Poisoning. Toxicol Int. 2015 Jan-Apr;22(1):170-1. Go to original source... Go to PubMed...
  18. Ittyachen AM, George GR, Radhakrishnan M, Joy Y. Eucalyptus oil poisoning: two case reports. J Med Case Rep. 2019 Nov 4;13(1):326. Go to original source... Go to PubMed...
  19. Patel S, Wiggins J. Eucalyptus oil poisoning. Arch Dis Child. 1980 May;55(5):405-6. Go to original source... Go to PubMed...
  20. Kumar A, Baitha U, Aggarwal P, Jamshed N. A fatal case of menthol poisoning. Int J Appl Basic Med Res. 2016 Apr-Jun;6(2):137-9. Go to original source... Go to PubMed...
  21. Baibars M, Eng S, Shaheen K, Alraiyes AH, Alraies MC. Menthol toxicity: an unusual cause of coma. Case Rep Med. 2012:187039. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.